Molecular Evolution of Respiratory Syncytial Virus...

Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010 - Volume 18, Number 1—January 2012 - Emerging Infectious Diseases journal - CDC

Abstract

To assess molecular evolution of the respiratory syncytial virus (RSV) fusion gene, we analyzed RSV-positive specimens from 123 children in Canada who did or did not receive RSV immunoprophylaxis (palivizumab) during 2006-2010. Resistance-conferring mutations within the palivizumab binding site occurred in 8.7% of palivizumab recipients and none of the nonrecipients.

Authors

Papenburg J; Carbonneau J; Hamelin M-È; Isabel S; Bouhy X; Ohoumanne N; Déry P; Paes BA; Corbeil J; Bergeron MG

Journal

Emerging Infectious Diseases, Vol. 18, No. 1, pp. 120–124

Publisher

Centers for Disease Control and Prevention (CDC)

Publication Date

January 1, 2012

DOI

10.3201/eid1801.110515

ISSN

1080-6040

Associated Experts

Bosco Paes

Professor Emeritus, Faculty of Health Sciences

Visit profile

Labels

Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010 - Volume 18, Number 1—January 2012 - Emerging Infectious Diseases journal - CDC

Abstract

Authors

Journal

Publisher

Publication Date

DOI

ISSN

Associated Experts

Labels

Fields of Research (FoR)

Sustainable Development Goals (SDG)

Medical Subject Headings (MeSH)

Contact the Experts team